TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Hypertension occurrence during DKA episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incremental HZ cases avoided
Endpoint domain: Mortality/survival
Primary endpoint: Incremental PMPM budget impact
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficacy of 60-min PE compared to 90-min PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of improvement per session for PCL-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in parental stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain scores on injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset time of anesthetizing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to sensation return
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target Vessel Failure (TVF) rates
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of HAM-A total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Itch score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life improvement (EuroQol EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intubation or death
Endpoint domain: Mortality/survival
Primary endpoint: Subjective perception of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Overall scores of the real daily life and tasks questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oxidative stress as plasma free radicals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bilateral shear modulus discrepancy (Δshear modulus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional capacity (30STS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall pain occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure to remain on assisted ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Completion of MyDiabetesPlan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CDAI remission at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day overall mortality
Endpoint domain: Mortality/survival
Primary endpoint: colony counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serum sodium level increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in neurocognitive function (MoCA score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thermal comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: thermal sensation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional status at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcomes from BCG intravesical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detection of SSIs post-discharge
Endpoint domain: Adverse events/effects
Primary endpoint: acute vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: acute nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: delayed vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: delayed nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Application for rehabilitation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: behavioral intentions to reduce alcohol consumption
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: action plans to change future health behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: breast cancer worry
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: angle widening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in monthly migraine days (MMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early recurrence (ER)
Endpoint domain: Mortality/survival
Primary endpoint: Late recurrence (LR)
Endpoint domain: Mortality/survival
Primary endpoint: Amplification rate of SSR markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transferability of SSR markers among Lycoris species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic diversity evaluation of L. radiata lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver sense of competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy for diagnosing nutritional ketosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oxygen-desaturation index (ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time spent with oxygen saturation of <90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: reduced cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Median pharyngeal closure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VL completion at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VS (Viral Suppression)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial-Vitiligo Area Scoring Index percent change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV exposure prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of HBV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: T1 substaging feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Inhibition of IL6 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in CD4+ and CD8+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytotoxic activity of PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse effects (nausea, vomiting, drowsiness, pruritus)
Endpoint domain: Adverse events/effects
Primary endpoint: Smear cellularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid on-site cytology evaluation adequacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported leisure activity score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: motivation for physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Menopausal-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incidence of maternal fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experiences of reproductive-age women entering care for OUD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean quiz scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: TLF rate at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Definite or probable ScT rate
Endpoint domain: Adverse events/effects
Primary endpoint: Twelve-month primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of stent fractures
Endpoint domain: Adverse events/effects
Primary endpoint: First attempt intubation failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early intubation related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Transfer to acute care facilities
Endpoint domain: Mortality/survival
Primary endpoint: Interrupted stroke rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: de novo SUI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POP recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (EQ-5D VAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: congested nose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of early postoperative wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative MoCA score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intraoperative rScO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for predicting Lauren type of gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy for predicting Lauren type of gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for predicting Lauren type of gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: state mindfulness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BFox
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MFO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of SiSBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of SiDBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of 24 hrs mean ASBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CMR LVEF% at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life improvement (I-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: decrease in oral malodor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in RPE (Rate of Perceived Exertion)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Monetary savings per worker
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Usability of diabetes apps
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean percentage reductions in Mf counts at 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced hospital readmissions
Endpoint domain: Mortality/survival
Primary endpoint: superficial skin infections
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients developing Metabolic Syndrome (MetS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum alanine aminotransferase (ALT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: serum aspartate aminotransferase (AST) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: fatty liver grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Central Macular Thickness (CMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Total Macular Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: scar roughness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: time to lactogenesis onset (LII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for antibiotic re-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: desaturations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Angle of Anterior Chamber (ACA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: % hepatic lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Matsuda ISI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma concentrations of lipids, lipoproteins, and uric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cardiac PE skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at postpartum visits
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Nonroutine clinic visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Profile of Mood States Short Form (POMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Color difference (ΔE) between opacities and sound enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social wellbeing recovery
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Extent of incisor intrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ergonomic comfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Expression of biomarkers related to ITCs functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Utilization of intervention contents
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Primary failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: performance scores for interprofessional collaboration
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good outcomes across social anxiety measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total translation (TT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Great saphenous vein reflux time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Peak reflux velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: OCT CST change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CI-DME presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in 8-OHdG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in androgen receptor expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average LC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biomarkers of inflammation (CRP, leukocytes, leukocyte-to-lymphocyte ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Celiac disease-specific autoantibody response to transglutaminase 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean best-corrected visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonoscopy rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean nicotine Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reductions in urges to smoke
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FLU-PRO score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total treatment compliance rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction rate of nursing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NRS‐2002 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurodevelopmental trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute postlaminectomy pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mobility (daily step count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rates defined by behavioral symptom abstinence and EDE global scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prevalence of poor sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean total dollars lost due to presenteeism
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Childbirth experiences assessed through CEQ2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VAS scores of labor pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain outcomes
Primary endpoint: C2C6AR as a predictor of difficult laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of second surgery after MUS
Endpoint domain: Mortality/survival
Primary endpoint: hospital discharge timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with postoperative bowel regimen
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gastroesophageal reflux disease (GERD) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastrin serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ability to identify a safe dose for their child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kidney outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sensitivity of platinum-based chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients who conceived
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of patients free of recurrence after 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Speed improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asparaginase activity above 100 IU/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Anti‐Asparaginase Antibodies (AAA)
Endpoint domain: Adverse events/effects
Primary endpoint: Incisional hernia rate
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive engagement with personal CVD risk profile
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Motivation and self-efficacy in health behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bioavailability of coffee phenolics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neck disability levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of all-cause death and hospitalization due to cardiovascular reasons
Endpoint domain: Mortality/survival
Primary endpoint: Adherence at 12-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Apolipoprotein-B (Apo-B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: assessment of alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: advice not to consume alcohol during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete care relevant to alcohol risk level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in radiographic bone dimensional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients treated for confirmed tuberculosis within 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients completing tuberculosis testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients receiving same-day treatment for confirmed tuberculosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes